Measured Wealth Private Client Group LLC Makes New Investment in Unum Group (NYSE:UNM)

Measured Wealth Private Client Group LLC purchased a new stake in shares of Unum Group (NYSE:UNM) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 7,276 shares of the financial services provider’s stock, valued at approximately $531,000.

Several other institutional investors also recently modified their holdings of UNM. Versant Capital Management Inc raised its position in Unum Group by 26.4% in the 4th quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock worth $56,000 after buying an additional 160 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of Unum Group by 28.8% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 800 shares of the financial services provider’s stock worth $58,000 after acquiring an additional 179 shares during the period. CIBC Asset Management Inc raised its holdings in shares of Unum Group by 3.4% during the third quarter. CIBC Asset Management Inc now owns 5,551 shares of the financial services provider’s stock valued at $330,000 after purchasing an additional 180 shares during the last quarter. V Square Quantitative Management LLC lifted its position in Unum Group by 38.2% during the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock valued at $42,000 after purchasing an additional 194 shares during the period. Finally, Brooklyn Investment Group boosted its holdings in Unum Group by 3.1% in the third quarter. Brooklyn Investment Group now owns 6,592 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 197 shares during the last quarter. 86.57% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group boosted their target price on shares of Unum Group from $91.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, December 10th. StockNews.com cut Unum Group from a “buy” rating to a “hold” rating in a research report on Thursday. Evercore ISI raised Unum Group from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $67.00 to $84.00 in a research report on Thursday, November 14th. Barclays upped their price target on shares of Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a research report on Monday, January 6th. Finally, Morgan Stanley raised their price objective on shares of Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 30th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $79.45.

Insider Transactions at Unum Group

In other Unum Group news, EVP Lisa G. Iglesias sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $72.61, for a total value of $363,050.00. Following the completion of the transaction, the executive vice president now directly owns 35,840 shares in the company, valued at $2,602,342.40. This represents a 12.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Richard P. Mckenney sold 58,865 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $75.39, for a total transaction of $4,437,832.35. Following the sale, the chief executive officer now directly owns 1,007,003 shares of the company’s stock, valued at approximately $75,917,956.17. This trade represents a 5.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 98,164 shares of company stock valued at $7,346,040 over the last 90 days. Company insiders own 0.93% of the company’s stock.

Unum Group Price Performance

NYSE UNM opened at $76.62 on Friday. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 12 month low of $46.64 and a 12 month high of $79.43. The stock has a market cap of $13.99 billion, a price-to-earnings ratio of 8.29, a PEG ratio of 1.08 and a beta of 0.80. The company’s 50 day moving average is $74.24 and its two-hundred day moving average is $65.08.

Unum Group (NYSE:UNM) last announced its quarterly earnings data on Tuesday, February 4th. The financial services provider reported $2.03 EPS for the quarter, missing the consensus estimate of $2.14 by ($0.11). Unum Group had a net margin of 13.76% and a return on equity of 15.21%. As a group, research analysts anticipate that Unum Group will post 8.54 earnings per share for the current year.

Unum Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be given a $0.42 dividend. The ex-dividend date of this dividend is Friday, January 24th. This represents a $1.68 annualized dividend and a dividend yield of 2.19%. Unum Group’s payout ratio is 18.18%.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.